First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia.

Authors :: Chabala, C.
Jacobs, T.G.
Moraleda, C.
Ndaferankhande, J.M.
Mumbiro, V.
Passanduca, A.
Namuziya, N.
Nalwanga, D.
Musiime, V.
Ballesteros, A.
Domínguez-Rodríguez, S.
Chitsamatanga, M.
Cassia, U.
Nduna, B.
Bramugy, J.
Sacarlal, J.
Madrid, L.
Nathoo, K.J.
Colbers, A.
Burger, D.M.
Mulenga, V.
Buck, W.C.
Mujuru, H.A.
Brake, L.H.M. te
Rojo, P.
Tagarro, A.
Aarnoutse, R.E.
Chabala, C.
Jacobs, T.G.
Moraleda, C.
Ndaferankhande, J.M.
Mumbiro, V.
Passanduca, A.
Namuziya, N.
Nalwanga, D.
Musiime, V.
Ballesteros, A.
Domínguez-Rodríguez, S.
Chitsamatanga, M.
Cassia, U.
Nduna, B.
Bramugy, J.
Sacarlal, J.
Madrid, L.
Nathoo, K.J.
Colbers, A.
Burger, D.M.
Mulenga, V.
Buck, W.C.
Mujuru, H.A.
Brake, L.H.M. te
Rojo, P.
Tagarro, A.
Aarnoutse, R.E.
Source :: Journal of the Pediatric Infectious Diseases Society, 12, 11, pp. 581-585
Publication Year :: 2023
Abstract: Contains fulltext : 299969.pdf (Publisher’s version ) (Open Access)<br />Optimal antituberculosis therapy is essential for favorable clinical outcomes. Peak plasma concentrations of first-line antituberculosis drugs in infants with living HIV receiving WHO-recommended dosing were low compared with reference values for adults, supporting studies on increased doses of first-line TB drugs in infants.

Database :: OAIster
Journal :: Journal of the Pediatric Infectious Diseases Society, 12, 11, pp. 581-585
Publication Type :: Electronic Resource
Accession number :: edsoai.on1414634341
Document Type :: Electronic Resource

Tools